Hindustan Foods Limited has announced the submission of the audio recording for its Analyst/Investors conference call held on May 22, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

During the conference call, the Senior Management of hindustan foods discussed the company's operational and financial performance for the quarter and fiscal year ended March 31, 2026. The session included an interactive question and answer segment with analysts and investors.

Accessing the Recording

The audio recording of the proceedings has been officially uploaded and is available for public access. Stakeholders can listen to the discussion via the investor relations section of the company's website.

The company has requested the stock exchanges to take this information on record. Bankim Dilip Purohit, Company Secretary and Legal Head, signed the submission on May 22, 2026.

Hindustan Foods Limited has announced its audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved the results at a meeting held on May 21, 2026, with statutory auditors M/s. MSKA & Associates LLP issuing an unmodified opinion on both consolidated and standalone financial statements. The company delivered broad-based growth across revenue and profitability metrics for both the quarter and the full year, while also securing new business wins and authorizing fresh capital investments to support its next phase of expansion.

Full Year Consolidated Performance

For the financial year ended March 31, 2026, Hindustan Foods reported a consolidated net profit (PAT) of ₹149.03 crore, an increase of 29% from ₹115.26 crore in the previous year. Total income rose 17% to ₹4,264.69 crore from ₹3,655.77 crore, while revenue from operations grew to ₹4,251.04 crore from ₹3,638.71 crore. EBITDA increased by 20% to ₹377.00 crore from ₹315.30 crore, and PBT before exceptional items rose 32% to ₹204.20 crore from ₹155.10 crore, marking the company's highest-ever annual profit after tax. The company has demonstrated consistent compounding growth, with revenue, EBITDA, PBT, and PAT recording compound growth rates of 20%, 34%, 30%, and 35% respectively from FY22 to FY26.

Quarterly Performance

In the quarter ended March 31, 2026, the consolidated net profit stood at ₹41.55 crore, up 32% compared to ₹31.55 crore in the corresponding quarter of the previous year. Total income for the quarter increased 17% to ₹1,120.91 crore from ₹961.81 crore in Q4 FY25. EBITDA for the quarter increased by 28% to ₹104.10 crore from ₹81.40 crore, with the EBITDA margin improving to 9.00% from 8.36% in the year-ago quarter. PBT before exceptional items rose 40% to ₹58.20 crore from ₹41.60 crore. The company reported an exceptional item of ₹1.07 crore during the quarter, related to an incremental liability for the Nashik Unit of Avalon Cosmetics on account of business combination.

Key Financial Metrics

The following table outlines the consolidated financial performance for the year and quarter ended March 31, 2026:

Standalone Results

The standalone financial results for the year ended March 31, 2026, showed a net profit of ₹119.37 crore, compared to ₹108.96 crore in the prior year. Revenue from operations for the standalone entity was ₹3,275.62 crore, an increase from ₹2,808.19 crore in FY25. Total standalone income for the year stood at ₹3,298.39 crore versus ₹2,829.29 crore previously. For the quarter, standalone net profit was ₹21.24 crore, with standalone revenue from operations at ₹851.70 crore. Standalone basic and diluted EPS for the full year stood at ₹9.89, compared to ₹9.31 in the prior year.

Balance Sheet and Cash Flow Highlights

The company's consolidated balance sheet as on March 31, 2026, reflects total assets of Rs. 3,173.71 crore, up from Rs. 2,551.51 crore as of March 31, 2025. Networth stood at Rs. 1,165.08 crore, while cash and cash equivalents were Rs. 35.87 crore. Net debt-to-equity remained at a comfortable 0.84x. The gross block including capital work-in-progress and capital advances reached more than Rs. 1,800 crore by March 2026, reflecting the commercialization of the most significant investment cycle in the company's history. Adjusted ROCE, after normalizing for underutilized and recently commissioned assets, stood at 18.9%, above the internal minimum threshold of 18%.

On cash flows, net cash from operating activities was Rs. 100.02 crore for FY26, compared to Rs. 118.47 crore in FY25. Cash flows were impacted by higher working capital deployment, driven by GST rate changes effective September 22, 2025, under the inverted duty structure, and proactive inventory build-up to ensure supply chain resilience amid geopolitical uncertainty.

Capital Investments and New Projects

The company signed up projects worth Rs. 780 crore in FY26, the highest annual project wins in the company's history. As of the date of the presentation, projects worth Rs. 550+ crore have already been commercialized, with the balance targeted for commercialization in H1 FY27. The Board of Directors has also authorized investments totaling ₹150 crore across three new facilities for FY27, targeting growth across its Beverage, Home and Personal Care (HPC), and Ice Cream segments. Gross block is projected to grow from Rs. 1,810 crore as of March 2026 to Rs. 2,150 crore by March 2027.

Segment Highlights

Across its business verticals, Hindustan Foods made significant operational progress in FY26. In the Home & Personal Care (HPC) segment, the Aurangabad personal care facility acquisition was completed with production commissioned from Q1 FY27, the Silvassa liquid detergent facility is to be commercialized in Q1 FY27, and the Lucknow detergent bars facility (Rs. 50 crore) is targeted for Q3 FY27. The Ice Cream segment saw record seasonal execution, with the Panipat plant (Rs. 225 crore, Phase 1) commercialized in April, and the Nashik and Lucknow plants already commercialized. A new North India ice cream manufacturing facility worth Rs. 50 crore is targeted for Q3 FY27. In Food & Beverages, capacity expansion ahead of the summer season enabled several factories to achieve their highest-ever production levels, with a new Greek yoghurt manufacturing facility in Goa (Rs. 40 crore) and a bottled water plant in Aurangabad (Rs. 30 crore) both targeted for Q3 FY27. The Healthcare division added new customers and expanded into wellness-led and Ayurveda-oriented categories, with an Ayurvedic wellness manufacturing facility in Baddi (Rs. 25 crore) to be commissioned in Q2 FY27. The Footwear division crossed an important turnover milestone, though it was the segment most affected by rising petrochemical prices during the year; capacity expansion in North and South India (Rs. 50 crore) is currently in progress.

Corporate Developments

During the year, two significant schemes of arrangement were approved by the Hon'ble National Law Tribunal (Mumbai Bench) vide its order dated February 25, 2026. The merger of the Contract Manufacturing (Nashik) Business unit of Avalon Cosmetics Private Limited into Hindustan Foods Limited was made effective from April 1, 2024 as the appointed date, with the company allotting 1,680,939 equity shares of Rs. 2 each to shareholders of Avalon Cosmetics. Separately, the amalgamation of Vanity Case India Private Limited (VCIPL) into Hindustan Foods Limited was also approved, with the company allotting 46,458,145 equity shares of Rs. 2 each to VCIPL shareholders. Both schemes have been accounted under the pooling of interests method, and prior period financial information has been restated accordingly. Additionally, the company executed a Business Transfer Agreement with Ultra Beauty Care Private Limited for acquisition of its manufacturing facilities at Aurangabad, Maharashtra, for a purchase consideration of Rs. 19.90 crore on a slump sale and going concern basis, effective from April 1, 2026.

Management Commentary

Commenting on the results, Sameer R. Kothari, Managing Director, said, "We are proud to report record numbers for FY26 because they truly represent the successful implementation of a series of transformative initiatives taken over the last 4 years. As a part of this transformation, HFL undertook an ambitious capex goal of investing more than Rs. 700 crores. This capex has enabled us to deliver capacities across geographies and product categories laying a strong foundation for continued compounding growth across revenues, profitability and manufacturing capabilities. HFL has transitioned from being a large, diversified Contract Manufacturer to a broad based manufacturing platform servicing marquee and emerging customers across multiple product categories and sectors. With a strong pipeline and improving utilisation across facilities, we remain confident in our ability to sustain profitable growth and deliver on our FY27 PAT guidance."

Ganesh Argekar, Executive Director, noted that Q4 FY26 capped a year of strong operational execution across the manufacturing network, with all divisions performing well. He highlighted that seasonal businesses like Beverages and Ice Cream delivered record volume growth, while the smooth commissioning of newer factories and integration of acquisitions further added to performance. He also noted that the footwear division bore the brunt of the rise in petrochemical prices during the quarter, and that the focus for FY27 will be on accelerating utilization ramp-up across recently commissioned assets and continuing to judiciously invest in new capex.

Mayank Samdani, Group CFO, highlighted that FY26 saw the commercialization of the most significant investment cycle in the company's history, with gross block including capital work in progress and capital advances reaching more than Rs. 1,800 crores by March 2026. He noted that adjusted ROCE, after normalizing for underutilized and recently commissioned assets, remains above the internal minimum threshold of 18%, and that net debt-to-equity remains at a comfortable 0.84x. He also indicated that certain businesses will transition from gross to net revenue recognition from Q3 FY27 onwards, which will have no impact on absolute profitability, though it will moderate reported revenues for those businesses.